InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Anderson Kenneth Carl, Director. Officer active across 1 companies, notably C4 Therapeutics, Inc.. Aggregated, 9 filings have been logged. The latest transaction was disclosed on 4 April 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
€8,221341 shares@ €24.10740.0044% mcap14.5% of flow
Common Stock
SEC:0001209191-22-023016:0·
€1,499803 shares@ €1.86650.0008% mcap6.2% of flow
Common Stock
SEC:0001209191-22-005107·
€1,499803 shares@ €1.86650.0008% mcap2.7% of flow
Common Stock
SEC:0001209191-22-005107:0·
€7,768278 shares@ €27.94140.0042% mcap32.2% of flow
Common Stock
SEC:0001209191-22-003500·
€7,768278 shares@ €27.94140.0042% mcap13.7% of flow
Common Stock
SEC:0001209191-22-003500:0·
€7,512194 shares@ €38.72290.0041% mcap31.1% of flow
Common Stock
SEC:0001209191-21-059515·
€7,512194 shares@ €38.72290.0041% mcap13.3% of flow
Common Stock
SEC:0001209191-21-059515:0·
€7,377220 shares@ €33.52960.0040% mcap30.5% of flow
Common Stock
SEC:0001209191-21-045806·
€7,377220 shares@ €33.52960.0040% mcap13.0% of flow
Common Stock
SEC:0001209191-21-045806:0·
9 of 9 declarations
About Anderson Kenneth Carl
Anderson Kenneth Carl serves as a Board Member at C4 Therapeutics, Inc. He is involved in overseeing the company's operations and strategic decisions. Kenneth brings expertise in biotechnology and research, which is essential for the development of C4 Therapeutics' business. His role on the board contributes to growth and innovation.
